Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Hyperfine Inc (HYPR)

Hyperfine Inc (HYPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 60,798
  • Shares Outstanding, K 71,950
  • Annual Sales, $ 11,030 K
  • Annual Income, $ -44,240 K
  • 60-Month Beta 0.75
  • Price/Sales 5.42
  • Price/Cash Flow N/A
  • Price/Book 0.71
Trade HYPR with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.62
  • Most Recent Earnings $-0.15 on 03/21/24
  • Latest Earnings Date 05/09/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 428.47% ( -287.93%)
  • Historical Volatility 66.46%
  • IV Percentile 89%
  • IV Rank 41.75%
  • IV High 981.62% on 04/16/24
  • IV Low 32.04% on 05/15/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 40
  • Volume Avg (30-Day) 43
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 492
  • Open Int (30-Day) 551

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.14
  • Number of Estimates 2
  • High Estimate -0.14
  • Low Estimate -0.14
  • Prior Year -0.17
  • Growth Rate Est. (year over year) +17.65%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7951 +4.35%
on 04/18/24
1.0800 -23.18%
on 04/10/24
-0.1703 (-17.03%)
since 03/28/24
3-Month
0.7951 +4.35%
on 04/18/24
1.3900 -40.31%
on 02/29/24
-0.2603 (-23.88%)
since 01/29/24
52-Week
0.7951 +4.35%
on 04/18/24
3.2800 -74.70%
on 07/18/23
-0.5803 (-41.16%)
since 04/28/23

Most Recent Stories

More News
AxoGen (AXGN) Reports Q1 Loss, Tops Revenue Estimates

AxoGen (AXGN) delivered earnings and revenue surprises of 33.33% and 2.41%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

AXGN : 6.63 (+0.30%)
HYPR : 0.8237 (-2.52%)
Tactile Systems Technology (TCMD) Reports Q1 Loss, Tops Revenue Estimates

Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 88.89% and 8.33%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

TCMD : 14.04 (-1.82%)
HYPR : 0.8237 (-2.52%)
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Lags Revenue Estimates

Tandem Diabetes Care, Inc. (TNDM) delivered earnings and revenue surprises of -12.50% and 1.29%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

TNDM : 36.87 (+4.63%)
HYPR : 0.8237 (-2.52%)
Take the Zacks Approach to Beat the Market: Microsoft, Novo Nordisk, General Mills in Focus

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.

MSFT : 401.36 (-1.22%)
NVO : 126.89 (+0.03%)
HSY : 191.92 (+3.09%)
GIS : 70.36 (-0.66%)
CHD : 106.92 (+0.56%)
LULU : 361.66 (-0.83%)
ROL : 44.67 (-0.51%)
NOBL : 97.28 (+0.41%)
VIST : 43.43 (+0.91%)
PNTG : 20.58 (-0.96%)
HYPR : 0.8237 (-2.52%)
Avis Budget Group and Vulcan Materials have been highlighted as Zacks Bull and Bear of the Day

Avis Budget Group and Vulcan Materials have been highlighted as Zacks Bull and Bear of the Day.

CAR : 104.22 (+3.44%)
VMC : 260.60 (-0.24%)
OMER : 3.13 (-0.63%)
LNTH : 67.34 (+2.72%)
HYPR : 0.8237 (-2.52%)
3 Medical Stocks Creating Wealth Despite Macro Challenges

Here we discuss three stocks - LNTH, OMER and HYPR - that have been creating wealth for their investors in 2023 even though several competitors faltered amid macro challenges. Will the trend continue?

OMER : 3.13 (-0.63%)
LNTH : 67.34 (+2.72%)
HYPR : 0.8237 (-2.52%)
Pre-Market Brief: Stocks Climb on Hopes of Fed Pivot

December S&P 500 futures (ESZ22) are trending higher +1.42% this morning, following a strong rally among three major US benchmark indices during the regular session as weaker than anticipated ISM manufacturing...

ESZ22 : 3,871.47s (-0.66%)
RIVN : 9.36 (+3.54%)
AERC : 3.40 (+0.59%)
XOS : 7.53 (-0.40%)
BFLY : 0.8084 (+3.80%)
AXTI : 3.04 (+2.36%)
HYPR : 0.8237 (-2.52%)
Hyperfine Reports Second Quarter 2022 Financial Results

GUILFORD, Conn., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI...

HYPR : 0.8237 (-2.52%)
Viz.ai Partners with Hyperfine to Enable New MR Imaging and Workflow Paradigm

Viz.ai , the leading AI-powered disease detection and intelligent care coordination platform , announced today it is partnering with Hyperfine, Inc. (Nasdaq: HYPR), creator of the first FDA-cleared...

HYPR : 0.8237 (-2.52%)
Hyperfine to Announce Second Quarter 2022 Financial Results on August 10, 2022

GUILFORD, Conn., July 20, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI...

HYPR : 0.8237 (-2.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Hyperfine Inc. is a groundbreaking medical device company which created Swoop(R), first FDA-cleared portable MRI system(TM). Hyperfine Inc., formerly known as HealthCor Catalio Acquisition Corp., is based in GUILFORD, Conn.

See More

Key Turning Points

3rd Resistance Point 0.8932
2nd Resistance Point 0.8735
1st Resistance Point 0.8593
Last Price 0.8237
1st Support Level 0.8254
2nd Support Level 0.8057
3rd Support Level 0.7915

See More

52-Week High 3.2800
Fibonacci 61.8% 2.3308
Fibonacci 50% 2.0375
Fibonacci 38.2% 1.7443
Last Price 0.8237
52-Week Low 0.7951

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar